Simulect
NDC 0078-0331, basiliximab, injection, powder, for solution, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0331
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103764
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0331 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BASILIXIMAB20 mg/5mL
Pharmacologic classes
Interleukin 2 Receptor Antagonists [MoA]; Interleukin 2 Receptor-directed Antibody Interactions [MoA]; Interleukin-2 Receptor Blocking Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0331-84 | 00078033184 | 1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1af01887-b69d-444b-91ed-ebfe12784440Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0078-0331
Use it
Look up 0078-0331 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0331 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0331. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.